Associated Papers
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.
Zhou Y et al.
Science Advances, 2023
37992168 (PubMed )
Supplement: sciadv.adg2263_tables_s1_to_s5.zip › adg2263_Table_S1.xlsx › Genomic_data
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
Ptashkin RN et al.
Nature Communications, 2023
37898613 (PubMed )
Supplement: 41467_2023_42585_MOESM1_ESM.pdf
Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
Wu X et al.
Bmc Cancer, 2022
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Nassar AH et al.
British Journal of Cancer, 2020
31857723 (PubMed )
Supplement: 41416_2019_686_MOESM1_ESM.xlsx › S1.2_Overall_SNV_small_indels
[Pedigree investigation of clinicopathologic features and alpha-galactosidase A gene mutation in a family with Fabry disease].
Liu XX et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition, 2012
[Investigation of family pedigree rare blood group of JK(a-b-) phenotype].
Gong TX et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2012
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhu JF et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2011
[Mutation of tet2 gene and malignant blood disease].
Qian XF et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2010
[Successful treatment of agammaglobulinemia by HLA-mismatched unrelated cord blood stem cell transplantation--the first case report].
Wan DM et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 2005
[Report of gene mutation hot spots analysis in one congenital cataract pedigree].
Zhang X et al.
Yan Ke Xue Bao = Eye Science, 2004
Select a paper to view details